Phase II study of erlotinib (Tarceva) and radiotherapy for elderly patients with esophageal carcinoma
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2016
At a glance
- Drugs Erlotinib (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Oct 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 28 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.